Haleon Group - Total Utang marang Modal HLN

Haleon Group - logo grafis emiten HLN

Haleon plc is a leading global player in the FMCG pharma segment with a global reach across the OTC market. The debt-to-equity ratio visualizes financial stability, while 0.47 reflects the baseline level of the metric. E-commerce growth and expansion in Asia support stable demand. A monopolistic focus on vitamins and hygiene guarantees predictable cash flows and strong margins.

Haleon (HLN): Rasio Kabeh Utang marang Dana Pribadi saka 28.04.2023 nganti 31.10.2026
Produk dadi haleon.com

Outsourcing production and distribution allows Haleon plc to optimize capital expenditures. The total debt-to-equity ratio measures the proportion of borrowed funds relative to equity, determining financial stability. A high value signals risks during rate hikes, while a low value indicates conservative growth. It is critical for investors to monitor the balance between leverage and liquidity. By analyzing changes in the business's leverage ratio, one can assess the issuer's current debt load.

Pesaing Haleon plc

KVUE (Kenvue) - Total Utang marang Modal|VRNA: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal MENS|Total Utang marang Modal Ligand Corp (LGND)|Utang marang Ekuitas Amneal Pharmaceuticals AMRX|Rasio Kabeh Utang marang Dana Pribadi PRGO|ALVO - Utang marang Ekuitas|Liquidia Corp (LQDA) - Rasio Total Utang marang Ekuitas|GLPG: Total Utang marang Modal|ANI Pharmaceuticals Corp (ANIP) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas MNKD|AMPH: Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Pacira BioSciences, Inc. (PCRX)|SPRY - Utang marang Modal|Theravance - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal AQST (Aquestive Corp)|scPharma - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi TECX (Tectonic Therapeutic, Inc.)|TNXP: Total Utang marang Modal|Utang marang Modal China SXT Pharmaceuticals, Inc. (SXTC)|Utang marang Ekuitas Eupraxia Pharmaceuticals, Inc.|BHST: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal EXOZ|ORMP (oramed.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal ENTX (Entera Bio)|Total Utang marang Modal MindWalk Holdings, Inc. HYFT|ABVC - Utang marang Ekuitas|CPIX: Utang marang Ekuitas|QNTM: Total Utang marang Modal|Utang marang Modal fibrogen.com (FGEN)|Utang marang Ekuitas Telomir Pharmaceuticals, Inc.|Utang marang Modal Rani Therapeutics Inc RANI|Utang marang Ekuitas Synergy CHC Corp (SNYR)|rallybio.com - Rasio Utang marang Ekuitas|Lexaria Bioscience Corp. - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi PULM|PTHL - Utang marang Ekuitas|Utang Agregat marang Ekuitas APM|Lyra Therapeutics, Inc (LYRA) - Utang marang Ekuitas|IBO (Impact BioMedical, Inc.) - Utang marang Ekuitas|TNFA (TNF Pharmaceuticals Inc.) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas cbdMD Corp (YCBD)|Total Utang marang Modal PRFX|CYTO (altamiratherapeutics.com) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Lipella LIPO|OptiNose Corp - Utang marang Ekuitas|PIRS - Utang marang Ekuitas|PROC (procapsgroup.com) - Rasio Utang marang Ekuitas|Petros Pharmaceuticals, Inc. (PTPI) - Utang marang Ekuitas|Utang Agregat marang Ekuitas QLI (Qilian International Holding Group)|SLRN (ACELYRIN, Inc.) - Total Utang marang Modal|TFFP: Rasio Kabeh Utang marang Dana Pribadi